4.7 Article

Binding of CpG oligodeoxynucleotides to mesoporous silica nanoparticles for enhancing delivery efficiency

期刊

MICROPOROUS AND MESOPOROUS MATERIALS
卷 204, 期 -, 页码 91-98

出版社

ELSEVIER
DOI: 10.1016/j.micromeso.2014.11.007

关键词

Mesoporous silica nanoparticles; CpG oligodeoxynucleotides; Gene delivery; Toll-like receptor 9

资金

  1. Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  2. National Natural Science Foundation of China [51102166]
  3. Program for New Century Excellent Talent in University [NCET-12-1053]
  4. Key Project of Chinese Ministry of Education [212055]
  5. Innovation Program of Shanghai Municipal Education Commission [12ZZ140]
  6. Shanghai Shuguang Project [12SG39]
  7. Hujiang Foundation of China [B14006]
  8. Training Program of University of Shanghai for Science and Technology [14XPY01]

向作者/读者索取更多资源

We developed a potential cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODN) delivery system by binding of CpG ODN onto aminated mesoporous silica nanoparticles (MSNs) to form CpG/MSN-NH2 complexes for Toll-like receptor 9 (TLR9)-mediated induction of cytokines. Serum stability, in vitro cytotoxicity, cellular uptake, and interleukin-6 (IL-6) induction of CpG/MSN-NH2 complexes were investigated. The results showed that MSN-NH2 nanopartides had no cytotoxicity to Raw 264.7 cells, and binding of CpG ODN to MSN-NH2 nanoparticles enhanced serum stability of CpG ODN due to the protection by nanoparticles. Furthermore, CpG/MSN-NH2 complexes could be efficiently taken up by cells due to small particle size and good dispersity. Most importantly, CpG/MSN-NH2 complexes significantly enhanced the level of IL-6 induction, stimulated by interaction between CpG ODN and TLR9 in endolysosomes. Therefore, MSNs would be a promising carrier for enhancing the delivery efficiency of CpG ODN. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据